ATRA

(redirected from all-transretinoic acid)
Also found in: Wikipedia.

ATRA

A vitamin-A analogue used to manage acute promelocytic leukaemia, with the translocation t(15;17) or typical PML-RAR gene rearrangement, as it prompts the leukaemic cells to maturation.

Adverse effects
Headaches, dry skin, mouth and eyes, nausea, bone pain.
References in periodicals archive ?
7] M all-transretinoic acid decreased the expression of MMP-9, and combined treatment with both all-trans-retinoic acid and P.
Hydroxypinacolone Retinoate is the cosmetic ester of all-transretinoic acid and, unlike retinol esters, does not require metabolic conversion to be in the preferred active form for interacting with retinoic RAR receptors to obtain benefits of vitamin A.
Mohamad Hussein, Cleveland Clinic Foundation, Taussig Cancer Center Monday, December, 6, 2004 at 1:30 pm PT Use of All-Transretinoic Acid (ATRA) + Arsenic Trioxide (ATO) To Eliminate or Minimize Use of Chemotherapy (CT) in Untreatable Acute Promyelocytic Leukemia (APL)-Oral Session Dr.
Phytanic acid and docosahexaenoic acid increase the metabolism of all-transretinoic acid and CYP26 gene expression in intestinal cells.
The patient was treated with high-dose all-transretinoic acid for 14 days, followed by a first induction chemotherapy regimen consisting of cytarabine, daunorubicine, and thioguanine.
There are two classes of retinoid receptor, the RAR or retinoic acid receptor, which binds all-transretinoic acid, and RXR, or the so-called orphan receptor whose ligand is believed to be 9-cis-retinoic acid.

Full browser ?